Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients.

Oncotarget · 2014 · PMC4148090 · PMID 25015728

Europe PMC DOI

hedged sentence

0.1536

closest p · 3.1× alpha

0.1536

boldest claim

The sentences

did not reach statistical significancep=0.1536not close (p > 0.1)

Evaluating only patients who did not receive any preoperative therapy (n=117), survival time analysis showed a marked favorable survival time in patients expressing nuclear IL-23p19 but this result did not reach statistical significance (p=0.1536).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.